Heart Test Laboratories
HSCS
10 hedge funds and large institutions have $610K invested in Heart Test Laboratories in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 3 closing their positions.
0% less capital invested
Capital invested by funds: $612K → $610K (-$1.38K)
0.4% less ownership
Funds ownership: 6.62% → 6.21% (-0.4%)
17% less funds holding
Funds holding: 12 → 10 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$42K |
| 2 |
DS
DRW Securities
Chicago,
Illinois
|
+$34K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$17.7K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.97K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$21 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$35.8K |
| 2 |
RFG
REAP Financial Group
Austin,
Texas
|
-$1.32K |
| 3 |
Citigroup
New York
|
-$49 |
HSCS Hedge Fund Activity: Q4 2025 in Review
10 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Heart Test Laboratories (HSCS) for Q4 2025, worth a combined $610K — down 0.23% from $612K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of HSCS and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 4 added.
The largest buyer was Geode Capital Management, adding an estimated $42K. The largest seller was Advisory Services Network, exiting entirely with an estimated $35.8K sold.
- 10 institutional investors held Heart Test Laboratories (HSCS) as of Q4 2025, down from 12 in Q3 2025.
- Funds reported $610K of Heart Test Laboratories stock for Q4 2025, down 0.23% quarter-over-quarter.
- 1 fund opened new Heart Test Laboratories positions in Q4 2025 and 3 closed out, a net change of -2 holders.
- The largest Heart Test Laboratories buyer in Q4 2025 was Geode Capital Management, an estimated $42K added.
- The largest Heart Test Laboratories seller in Q4 2025 was Advisory Services Network, an estimated $35.8K sold.
Based on aggregated 13F filings for Q4 2025.